͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 
Is this email not displaying correctly? View it in your browser.
Image description


Continuous Learning with Bioguard

Image description

A free online class brought to you by Bioguard

Get familiar with feline hyperthyroidism and its diagnosis and treatment methods.

Sponsored by Bioguard Corporation and presented by Dr. Sushant Sadotra, this is the next webinar you don't want to miss it.

Access to the on-demand recording is FREE

Obtain a CERTIFICATE of attendance

Image description


Oct 26

Image description

8 PM – 9 PM

Taipei Local Time


One of the most common diseases in middle-aged and older cats is hyperthyroidism. An increase in the production of thyroid hormones, i.e., T4 and T3, is the primary cause of this disorder. The enlarged thyroid gland in the neck region of the cat is the most common visible sign identifying hyperthyroidism. This enlargement is a non-cancerous tumor known as an adenoma. However, in some rare cases, it can also be caused by malignant tumors known as thyroid adenocarcinomas. Hyperthyroidism increases the metabolic rate in an animal's body because of high circulating thyroid hormone and often causes secondary problems by affecting all body organs.

The reason for feline hyperthyroidism is unfamiliar. However, deficiencies or excesses of some elements in the diet and thyroid-disrupting could be responsible for the onset of hyperthyroidism. Hyperthyroidism is rare in dogs. However, if it occurs, it is primarily because of thyroid carcinoma. This contrasts with the case in hyperthyroid cats, where less than 5% of a thyroid tumor is carcinoma. Therefore, early diagnosis with appropriate treatment is necessary to avoid complications.

In this webinar, different diagnoses for feline hyperthyroidism will be discussed that are currently being used in veterinary practices and animal hospitals. The advantages and disadvantages of various treatment methods will also be addressed. Overall, it will provide insight into the severity, accurate diagnosis, and better cure of this disease.


Dr. Sushant obtained his Ph.D. from National Tsing Hua University and Academia Sinica, Taiwan. He has expertise in biomarker discovery and protein structural biology with a strong research background in investigating potential biomarkers for target diseases. Currently, Dr. Sushant works as a diagnostic specialist with Bioguard Corporation (Taiwan).

Image description

Certificate of Attendance

eCertificate will be issued to the registered attendants joining the webinar for at least 50 minutes.

How to Join: Three Options:

Option 1: Watch via ZOOM

You can join us live directly via Zoom by simply registring. Please note that we will be sending you the link which is unique to you and should not be shared with anyone.

Option 2: Watch on our FACEBOOK Page

Follow our facebook page and join us live at the time of webinar.

Option 3: Watch at your LEISURE

By registering to attend this live webinar you will also gain access to the on-demand recording which will be available 24 hours later.


We look forward to seeing you at this event.

Happy Learning!

To Treat a Deadly Feline Coronavirus Disease, Clinical Trials have been launched by UC Davis

Image description

FIP is a severe disease caused by a feline coronavirus variant, though not the one that causes COVID-19. The virus will spread through a cat's body, causing systemic inflammation. Up to 95% of cats diagnosed with FIP die without treatment. Cats can develop FIP at any age, but it is usually diagnosed in cats between 6 months and two years. It is one of the most common causes of death in young cats with infectious diseases. Currently, no successful treatment is approved for veterinarians in the United States.

Trials will examine antiviral drugs, stem cell therapy

One trial will compare whether cats improve when treated with one of two closely related antiviral drugs. The first drug, remdesivir, is an antiviral drug with emergency authorization from the FDA to treat COVID-19. The second drug, GS-441524, is closely related to remdesivir. Pedersen found it safe and effective in treating cats with FIP.

The other trial will examine if antiviral drugs combined with a new stem cell therapy using mesenchymal stem cells, or MSCs, improve response to treatment for FIP. The study aims to see if cell therapy can direct a more effective antiviral immune response and help regenerate the cat's compromised immune system post-infection. For this study, one group will receive antiviral drugs along with infusions of MSCs, and the other will receive antiviral drugs and placebo infusions.

Read More

Want to stay up-to-date with what is going on?

Image description

FIP guidelines offer hope for quick diagnosis:

Image description

Oriental Shorthair with anterior uveitis, and corneal edema due to the development of glaucoma.

Courtesy of Lisa Callaway

"First recognized over 50 years ago, feline infectious peritonitis has been one of the most important infectious diseases and causes of death in cats, especially affecting young cats less than two years old," said Vicki Thayer, DVM, DABVP (Feline), Task Force Co-Chair. "Further, FIP can be challenging to diagnose in some cases and is often considered an enigma by the veterinary profession. Today, diagnosis relies upon evidence from signalment, history, physical examination findings, and diagnostic testing. The 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines serve as a critical resource for veterinary practitioners diagnosing FIP in their cat patients."

Given the fact that FIP is fatal when untreated and nearly every small animal veterinary practitioner will see FIP cases, the ability to obtain a correct diagnosis is critical. FIP can be challenging to diagnose due to the lack of clinical signs or laboratory changes, especially when no physical symptoms are present.

The 2022 AAFP / EveryCat Feline Infectious Peritonitis Diagnosis Guidelines will provide veterinarians with essential information to assist their ability to recognize cats presenting with FIP. The guidelines have been published in the Journal of Feline Medicine and Surgery.

Peritonitis Detection Kit, developed and manufactured by Bioguard Corporation, is fast, simple, and reliable for detecting or excluding Peritonitis in cats.

It can differentiate a transudate from an exudate. When the exudate contains reaction-positive proteins, it forms an effusion drop, precipitating in the reaction solution. The formation of precipitated products, teardrop-shaped mists, or smears can be observed during the test. In contrast, the transudate will completely dissolve in the reaction solution during the sedimentation.

Image description
Image description
Learn More

Good News, Coming Next Month!

Bioguard introduces the new "Babesia spp. Ab Rapid Test" kit

An excellent feature that can detect most of the major Babesia species

Including Babesia canis, Babesia vogeli, Babesia rossi, and Babesia gibsoni

Fit for all veterinarian's needs

Contact us directly at [email protected] for more information

Image description

About Bioguard Corporation

The Bioguard is a company focusing on animal disease diagnostic services and products.
Our animal health diagnostic center is the first and only ISO/ IEC 17025 accredited animal disease testing laboratory in Taiwan and China.

Copyright © Bioguard Corp., All rights reserved.

Our mailing address is: [email protected]

If you want to unsubscribe, click here.